Riskpilot← Back to searchSign inGet full accessZirq Medical A/S
A/SActiveCVR 36726008Stenlillevej 26Materials recovery · NACE 3821Est. 201519 employees
Revenue 2024
DKK 6,8M
+161% vs 2023
EBITDA margin
-45.0%
+50% vs 2023
Equity ratio
-58.9%
Financial strength
Net profit 2024
DKK -41,8M
-59% vs 2023
| Revenue | DKK 6,8M | +161% |
| EBITDA | DKK -3,1M | +50% |
| Net profit | DKK -41,8M | -59% |
| Total assets | DKK 114,4M | -15% |
| Equity | DKK -67,4M | -163% |
| Employees | 19 | — |
Legal name
Zirq Medical A/S
CVR number
36726008
Legal form
Aktieselskab
NACE code
3821 · Materials recovery
Founded
15. april 2015
Share capital
DKK 400.000
Employees
19 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den samlede direktion, eller af formanden for bestyrelsen.
Company purpose
Virksomhedens formål er at drive genbrugsvirksomhed med modtagelse og fordeling af jern og metalskrot, samt hvad som måtte stå i forbindelse med dette. Selskabet kan være deltager i andre selskaber og virksomheder.
Address
Stenlillevej 26
Phone
+4561884400
Email
rbn@nmtrade.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2.101 | 10.298 | 3.306 | 2.615 | 6.820 |
| Staff expenses | -2.734 | -3.144 | -6.808 | -8.747 | -9.890 |
| EBITDA | -637 | 7.154 | -3.502 | -6.136 | -3.070 |
| Depreciation & amort. | -519 | -690 | -1.971 | -2.749 | -3.621 |
| EBIT | -1.157 | 6.464 | -5.473 | -8.885 | -6.691 |
| Net financials | 360 | -13 | -518 | -21.611 | -38.125 |
| Profit before tax | -796 | 6.451 | -5.990 | -30.496 | -44.816 |
| Tax | -775 | 211 | -547 | -4.272 | -3.051 |
| Net profit | -22 | 6.240 | -5.443 | -26.224 | -41.765 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 5.106 | 9.032 | 161.285 | 134.005 | 114.373 |
| Equity | -5.134 | 5.289 | 638 | -25.586 | -67.351 |
| Long-term debt | 0 | 0 | 105.686 | 100.893 | 106.530 |
| Short-term debt | 10.240 | 3.634 | 54.636 | 58.698 | 75.193 |
| Total debt | 10.240 | 3.634 | 160.322 | 159.590 | 181.723 |
EBITDA margin
-45.0%
This company
15.8%
Market median
-385% vs market
20202024
Equity ratio
-58.9%
This company
38.2%
Market median
-254% vs market
20202024
Return on equity
-4176494600.0%
This company
18.4%
Market median
-22698340317% vs market
20202024
Net profit margin
-612.3%
This company
8.1%
Market median
-7659% vs market
20202024
Asset turnover
0.06×
This company
1.12×
Market median
-95% vs market
20202024
Debt / equity
2.70×
This company
0.62×
Market median
-335% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
PM Management | Management | 2025 |
| Former (8) | ||
OP Management | Management | 2019 – 2021 |
MB Chief Executive Officer | Chief Executive Officer | 2023 – 2024 |
SV Management | Management | 2018 – 2021 |
JV Chief Executive Officer | Chief Executive Officer | 2021 – 2023 |
EL Management | Management | 2018 – 2019 |
RB Management | Management | 2015 – 2021 |
RS Management | Management | 2021 – 2021 |
EK Management | Management | 2018 – 2019 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2025 | |
| Board of Directors | 2023 | |
| Chairman | 2025 | |
| Former (3) | ||
| Chairman | 2024 – 2024 | |
| Chairman | 2024 – 2024 | |
| Board of Directors | 2023 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Zirq Medical A/S 
LETBEK A/SBoard members of Zirq Medical A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ole Petter Nielsen | Management | 0 companies |
| Michael Bayer Thomsen | Chief Executive Officer | 0 companies |
| Stein Vegar Larsen | Management | 0 companies |
| Peter Michael Larsen | Management | 0 companies |
| Jesper Vinther Dueholm | Chief Executive Officer | 0 companies |
| Egil Lorentzen | Management | 0 companies |
| Rolf Bergerud Næslund | Management | 0 companies |
| Rune Stortiset | Management | 0 companies |
| Espen Krey Brettås | Management | 0 companies |
| Tone Leivestad | Board of Directors | 0 companies |
| Kristine Laake-Bjurquist | Board of Directors | 0 companies |
| Thomas Mørch | Chairman | 0 companies |
| Anette Nordskog | Chairman | 0 companies |
| Inga Gjervik | Board of Directors | 0 companies |
| Toni Pauli Ahtiainen | Chairman | 0 companies |